Lv1
80 积分 2023-06-16 加入
ECM1 protects against liver steatosis through PCBP1-mediated iron homeostasis
7天前
已完结
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation
7天前
已完结
Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis B
7天前
已完结
A Pharmacokinetic/Pharmacodynamic Drug–Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs
10天前
已完结
Pharmacokinetics and Pharmacodynamics of Tofogliflozin (a Selective SGLT2 Inhibitor) in Healthy Male Subjects
11天前
已完结
Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation
11天前
已完结
Clinical development of metformin extended-release tablets for type 2 diabetes: an overview
11天前
已完结
Efficacy, dose–response relationship and safety of once‐daily extended‐release metformin (Glucophage® XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double‐blind, placebo‐controlled studies
11天前
已完结
[Efficacy and safety of extended-release metformin in treatment of type 2 diabetes mellitus]
11天前
已关闭
Pharmacodynamics and pharmacokinetics of extended‐release metformin in patients with type 2 diabetes and chronic kidney disease stage 3B
11天前
已完结
皖公网安备34019202002308
